Bespoke Extracts (BSPK) Stock Analysis & Winston Score
Bespoke Extracts is a small cannabis company that makes hemp-derived CBD products. Its main products include CBD tinctures, gummies, and other wellness supplements sold directly to consumers and through retail partners. The company operates in the legal hemp market, which was opened up in the United States after the 2018 Farm Bill made hemp-derived CBD federally legal. The company earns revenue primarily through direct-to-consumer online sales and wholesale distribution to retailers. It operates mainly in the United States and is a very small player in a crowded CBD market with hundreds of competing brands. The operating margin is deeply negative, meaning the company spends far more than it earns, which is a serious financial risk. The biggest challenge ahead is standing out in an oversaturated market while managing cash burn, as many small CBD companies have struggled to survive without a clear brand advantage or path to profitability.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Weak (6/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.10
Market Cap: $1M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

